adMare BioInnovations (adMare) is pleased to announce the acceptance of five therapeutics start-ups from across…
karnottMay 24, 2024
High-grade serous ovarian cancer (HGSC) is a challenging disease, especially for patients with immunologically “cold”…
karnottMay 23, 2024
New evidence underscores the importance of conducting follow-up biopsies in children after treatment for rejection…
karnottMay 23, 2024
The effectiveness of radiotherapy depends on the sensitivities of ‘normal’ and cancer cells to the…
karnottMay 22, 2024
An interdisciplinary UBC team led by Dr. Peter Zandstra has received $1.65 million in federal…
karnottMay 22, 2024
Congratulations to Emily Yeh (Terry Fox Laboratory), for receiving a Canada Graduate Scholarships - Master's…
karnottMay 21, 2024
A growing body of evidence shows that the granzyme family of enzymes offer new pathways…
karnottMay 21, 2024
An early report on the molecular subtyping of muscle-invasive bladder cancer (MIBC) by gene expression…
sciencecityApril 24, 2017
Tyrosine kinase inhibitor (TKI) therapies induce clinical remission with remarkable effects on chronic myeloid leukemia…
sciencecityApril 17, 2017
Alterations in cellular aging, indexed by leukocyte telomere length (LTL) and mitochondrial DNA copy number…
sciencecityApril 10, 2017
Background People with Parkinson's disease can show premotor neurochemical changes in the dopaminergic and non-dopaminergic…
sciencecityApril 3, 2017
Background Clinical grading systems using clinical features alongside nomograms lack precision in guiding treatment decisions…
sciencecityMarch 27, 2017
ABSTRACT: Nonsense mutations underlie about 10% of rare genetic disease cases. They introduce a premature termination…
sciencecityMarch 20, 2017
ABSTRACT: A mild and selective photocatalytic C-H 18F-fluorination reaction has been developed that provides direct…
sciencecityMarch 13, 2017
ABSTRACT: CDC-like kinase phosphorylation of serine/arginine-rich proteins is central to RNA splicing reactions. Yet, the…
sciencecityMarch 8, 2017
Biomedical engineer Carl de Boer is taking a different approach to understanding how the genome works. Most…
pthomsonJune 8, 2022
Over the past 20 years, scientists have made great strides in understanding the brain and…
pthomsonJune 6, 2022
Over half a million Canadians are currently living with Alzheimer’s disease or a related form…
pthomsonJune 5, 2022
A small percentage of hormone-sensitive prostate cancer patients develop metastases in the lung after localized…
pthomsonJune 2, 2022
There have been a lot of headlines of late warning about Canada’s “data deficit,” the…
pthomsonJune 2, 2022
The COVID-19 pandemic ushered in a new type of vaccine that had never been approved before: messenger…
pthomsonJune 1, 2022
There’s tough, and then there’s Tough. It’s unlikely anyone would ever say that Dr. Emmanuel Twumasi…
pthomsonJune 1, 2022
Dr. Ly Vu from the Terry for Laboratories has received a prestigious three-year Basic/Translational Fellow…
sciencecityFebruary 3, 2020
New research is always exciting, but in order to spread the word about new findings,…
sciencecityJanuary 31, 2020
UBC researchers have been awarded $36.6M for 58 projects at the university and its affiliated health authority…
sciencecityJanuary 30, 2020
Using gene therapy to treat congenital blindness Aniridia is an eye disorder where the iris,…
sciencecityJanuary 22, 2020
Over the past five years, the Travel Awards provided by the Centre for Blood Research…
sciencecityJanuary 20, 2020
Twenty-six research excellence clusters led by researchers on the Vancouver campus will be funded through…
sciencecityJanuary 15, 2020
Congratulations to Dr. Ly Vu who has been awarded a three-year Basic/Translational Fellow to Faculty…
sciencecityJanuary 14, 2020
Dr. Wilfred Jefferies at the Michael Smith Laboratories has been elected as a Fellow of…
sciencecityJanuary 6, 2020
